TP53 Status and Estrogen Receptor-Beta in Triple-Negative Breast Cancer: Company Matters

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1118-1119
Number of pages2
JournalJournal of the National Cancer Institute
Volume111
Issue number11
DOIs
StatePublished - Nov 1 2019

Fingerprint

Triple Negative Breast Neoplasms
Estrogen Receptor beta

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{a6ae8cf8843349e18a475ad965c5c321,
title = "TP53 Status and Estrogen Receptor-Beta in Triple-Negative Breast Cancer: Company Matters",
author = "Badve, {Sunil S.} and Yesim G{\"o}kmen-Polar",
year = "2019",
month = "11",
day = "1",
doi = "10.1093/jnci/djz052",
language = "English (US)",
volume = "111",
pages = "1118--1119",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - TP53 Status and Estrogen Receptor-Beta in Triple-Negative Breast Cancer

T2 - Company Matters

AU - Badve, Sunil S.

AU - Gökmen-Polar, Yesim

PY - 2019/11/1

Y1 - 2019/11/1

UR - http://www.scopus.com/inward/record.url?scp=85075094086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075094086&partnerID=8YFLogxK

U2 - 10.1093/jnci/djz052

DO - 10.1093/jnci/djz052

M3 - Article

C2 - 30989234

AN - SCOPUS:85075094086

VL - 111

SP - 1118

EP - 1119

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 11

ER -